TerminatedPhase 4

Exploration of Pupil Dilation in Horner's Patients Taking Flomax

Stopped: incomplete enrollment

United States1 participantsStarted 2018-09-21

Plain-language summary

This study is evaluating the pupil dilation of Horner's Patients who have ever taken an alpha blocker such as Tamsulosin. Patients will undergo eye dilation as would occur at a yearly eye examination, but their pupil dilation measurements will be recorded.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Horner's Syndrome
✓. History of taking an alpha blocker (tamsulosin/ terazosin/doxazosin/alfuzosin/silodosin) medication

Exclusion criteria

✕. Subjects with untreated hypertension
✕. Subjects with thyrotoxicosis
✕. Pregnant women
✕. Prisoners
✕. Inability to consent
✕. Subjects with anatomical narrow angles who have never had a dilated exam

What they're measuring

Pupil Size Measurements

Timeframe: 20-30 minutes after 10% phenylephrine has been placed in each eye.

Trial details

NCT IDNCT03615508

SponsorDenver Health and Hospital Authority

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-05-01

Results submitted2020-08-21

View on ClinicalTrials.gov More Horner Syndrome trials